BioXcel Therapeutics, Inc. (BTAIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0075
-0.0013 (-14.77%)
At close: Nov 6, 2026
BioXcel Therapeutics Employees
BioXcel Therapeutics had 29 employees as of December 31, 2025. The number of employees decreased by 8 or 21.62% compared to the previous year. That makes BioXcel Therapeutics the 37,240th largest employer in the world and 5,185th in the United States.
Employees
29
Change (1Y)
-8
Growth (1Y)
-21.62%
Revenue / Employee
$25,586
Profits / Employee
-$2,443,448
Market Cap
234.79K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | -8 | -21.62% |
| Dec 31, 2024 | 37 | -37 | -50.00% |
| Dec 31, 2023 | 74 | -109 | -59.56% |
| Dec 31, 2022 | 183 | 94 | 105.62% |
| Dec 31, 2021 | 89 | 39 | 78.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bright Green | 5 |
| Fifty 1 Labs | 2 |
| Real Brands | 1 |
| Bakhu Holdings | 1 |
| Trafalgar International | 1 |
BioXcel Therapeutics News
- 2 months ago - BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals - GlobeNewsWire
- 2 months ago - Biopharma firm BioXcel Therapeutics files for bankruptcy in US - Reuters
- 2 months ago - BioXcel Therapeutics Quarterly report: Q2 2026 - Filings
- 5 months ago - BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting - GlobeNewsWire
- 5 months ago - BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 5 months ago - BioXcel Therapeutics Quarterly report: Q1 2026 - Filings
- 5 months ago - BioXcel Therapeutics Earnings release: Q1 2026 - Filings
- 6 months ago - BioXcel Therapeutics Transcript: Investor update - Transcripts